Literature DB >> 7724441

Effect of Helicobacter pylori eradication on peptic ulcer healing.

H J O'Connor1, C Kanduru, A S Bhutta, J M Meehan, K M Feeley, K Cunnane.   

Abstract

In a prospective study designed to assess the effect of Helicobacter pylori eradication on peptic ulcer healing, 85 consecutive patients with H. pylori-positive peptic ulcer disease were treated with a triple therapy regimen consisting of colloidal bismuth subcitrate 120 mg four times daily for 28 days, with metronidazole 400 mg three times daily and tetracycline 500 mg three times daily for the first seven days of treatment. H. pylori status was assessed by CLO test and histology at least four weeks after completing therapy. Of 75 patients (88%) H. pylori-negative after therapy, 69 (92%) had healed ulcers compared with only five of 10 patients (50%) who remained H. pylori-positive (p = 0.003). Cigarette smoking had no significant effect on ulcer healing. Our results suggest that H. pylori eradication may accelerate ulcer healing and provide further evidence that an effective helicobactericidal regimen is the treatment of choice in H. pylori-positive peptic ulcer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724441      PMCID: PMC2397943          DOI: 10.1136/pgmj.71.832.90

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

1.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Campylobacter pylori and peptic ulcer disease.

Authors:  H J O'Connor; M F Dixon; J I Wyatt; A T Axon; E P Dewar; D Johnston
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

4.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

5.  Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis.

Authors:  E M Witteman; W P Hopman; M C Becx; R W De Koning; G N Tytgat; A J Janssen; J B Jansen
Journal:  Aliment Pharmacol Ther       Date:  1993-12       Impact factor: 8.171

6.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

7.  Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.

Authors:  D Y Graham; G M Lew; D G Evans; D J Evans; P D Klein
Journal:  Ann Intern Med       Date:  1991-08-15       Impact factor: 25.391

8.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

9.  Cure of duodenal ulcer after eradication of Helicobacter pylori.

Authors:  L L George; T J Borody; P Andrews; M Devine; D Moore-Jones; M Walton; S Brandl
Journal:  Med J Aust       Date:  1990-08-06       Impact factor: 7.738

10.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

View more
  6 in total

1.  Eradication of Helicobacter pylori: the results of a pilot study of 3, 5 & 7 day triple antibiotic regime with bismuth for one month.

Authors:  H J O'Connor; K Cunnane; J S Collins; J M Sloan; B T Johnston; K C Bamford; J Gilvarry; C A O'Morain
Journal:  Ir J Med Sci       Date:  1997 Jan-Mar       Impact factor: 1.568

Review 2.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

3.  Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.

Authors:  H J O'Connor; C Stewart; R Walsh; C N McGee; B Flynn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

4.  In vitro bactericidal activities of Japanese rice-fluid against Helicobacter pylori strains.

Authors:  Yoshiyuki Kawakami; Kozue Oana; Masayoshi Hayama; Hiroyoshi Ota; Masahiko Takeuchi; Kazuhiro Miyashita; Tsunetomo Matsuzawa; Kiyomi Kanaya
Journal:  Int J Med Sci       Date:  2006-07-12       Impact factor: 3.738

Review 5.  Significance of dormant forms of Helicobacter pylori in ulcerogenesis.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Magomedalievna Reshetnyak
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

6.  Team dynamics in emergency surgery teams: results from a first international survey.

Authors:  Lorenzo Cobianchi; Francesca Dal Mas; Maurizio Massaro; Paola Fugazzola; Federico Coccolini; Yoram Kluger; Ari Leppäniemi; Ernest E Moore; Massimo Sartelli; Peter Angelos; Fausto Catena; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2021-09-16       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.